These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16823179)

  • 1. The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patient.
    Husdal A; Bukholm G; Bukholm IR
    Cell Oncol; 2006; 28(3):107-16. PubMed ID: 16823179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
    Bondi J; Husdal A; Bukholm G; Nesland JM; Bakka A; Bukholm IR
    J Clin Pathol; 2005 May; 58(5):509-14. PubMed ID: 15858123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
    Agarwal R; Gonzalez-Angulo AM; Myhre S; Carey M; Lee JS; Overgaard J; Alsner J; Stemke-Hale K; Lluch A; Neve RM; Kuo WL; Sorlie T; Sahin A; Valero V; Keyomarsi K; Gray JW; Borresen-Dale AL; Mills GB; Hennessy BT
    Clin Cancer Res; 2009 Jun; 15(11):3654-62. PubMed ID: 19470724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.
    Cassia R; Moreno-Bueno G; Rodríguez-Perales S; Hardisson D; Cigudosa JC; Palacios J
    J Pathol; 2003 Dec; 201(4):589-95. PubMed ID: 14648662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time.
    Bukholm IR; Husdal A; Nesland JM; Langerød A; Bukholm G
    Breast Cancer Res Treat; 2003 Jul; 80(2):199-206. PubMed ID: 12908823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression.
    Wani G; Noyes I; Milo GE; D'Ambrosio SM
    Mol Med; 1997 Apr; 3(4):273-83. PubMed ID: 9131589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma.
    Peng SY; Chou SP; Hsu HC
    J Hepatol; 1998 Aug; 29(2):281-9. PubMed ID: 9722210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
    Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL
    Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
    Jirström K; Stendahl M; Rydén L; Kronblad A; Bendahl PO; Stål O; Landberg G
    Cancer Res; 2005 Sep; 65(17):8009-16. PubMed ID: 16140974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and amplification of cyclin genes in human breast cancer.
    Buckley MF; Sweeney KJ; Hamilton JA; Sini RL; Manning DL; Nicholson RI; deFazio A; Watts CK; Musgrove EA; Sutherland RL
    Oncogene; 1993 Aug; 8(8):2127-33. PubMed ID: 8336939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
    Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
    Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
    Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
    Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ; Li SA; Tawfik O; Li JJ
    Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas.
    Bukholm IR; Bukholm G; Nesland JM
    Int J Cancer; 2001 Jul; 93(2):283-7. PubMed ID: 11410878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.